Today's News | Note: News feeds may no longer be available for the articles on this page.

Merck plans three-country cholesterol-drug launch 11:22 AM 5/19/2009
Forbes - NY,USA
Merck & Co will launch the cholesterol drug Tredaptive in Mexico, the United Kingdom, and Germany. The drug is approved to treat dyslipidemia and primary hypercholesterolemia outside the US where it is yet to be approved. ...

Health officials weigh supply of global flu vaccines 8:49 AM 5/19/2009
Reuters - USA
Often maligned, big pharma comes in handy when needed. UN Secretary-General Ban Ki-moon urged executives from 30 pharma companies to work to boost production of seasonal vaccines and to develop an injection against the newly-discovered H1N1 strain. ...

US, States Join Lawsuits on Wyeth Drug Sales 3:05 AM 5/19/2009
Wall Street Journal - USA
The lawsuits claim Wyeth avoided paying hundreds of millions of dollars in rebates to state Medicaid programs for its Protonix Oral and Protonix IV acid-reflux drugs. ...

Shire reports positive results for ADHD drug 3:19 PM 5/18/2009
Forbes - NY,USA
Shire said its experimental drug Intuniv significantly lowered defiant, angry behavior in children with attention-deficit hyperactivity disorder. ...

MannKind says FDA reviewing inhaled insulin 12:12 PM 5/18/2009
Forbes - NY,USA
MannKind Corp said that the US FDA will review the company's application for its experimental inhaled insulin Afresa for use in Type 1 or Type 2 diabetics to control high blood sugar levels. ...

Onyx sues Bayer for rights to Nexavar spinoff 10:07 AM 5/18/2009
Bizjournals.com - Charlotte,NC,USA
Onyx Pharmaceutical Inc filed a complaint against longtime partner Bayer claiming rights to a Phase II anti-cancer fluoro-sorafenib variant of their hot-selling drug Nexavar tablets. ...

Biovail to buy Huntington's disease drug rights 8:25 AM 5/18/2009
Reuters - USA
Cambridge Laboratories sells worldwide rights to its tetrabenazine product portfolio to Biovail Corp. Tetrabenazine treats chorea associated with Huntington's disease. ...

Japan's Takeda to buy IDM Pharma in cancer drug push 5:11 AM 5/18/2009
Reuters - USA
Takeda Pharmaceutical Co will buy US-based IDM Pharma for $75 million to bolster its presence in the cancer drug market. ...

Glaxo boosts cancer research with UK biotech deal 4:30 AM 5/18/2009
Reuters - USA
GlaxoSmithKline signs deal worth up to $370 million with privately held British biotech group Oxford BioTherapeutics to discover and develop new therapeutic antibodies for treating primary, metastatic, and recurring forms of cancer. ...

US reviewers question Debiovision, Salix drug data 1:53 PM 5/15/2009
Reuters - USA
Statistical reviews at the Food and Drug Administration found Debiovision's research does not support the efficacy of the drug Sanvar. ...

Gilead files 2nd patent suit against Teva 12:23 PM 5/15/2009
Bizjournals.com - Charlotte,NC,USA
Gilead Sciences filed a second lawsuit in US District Court against Teva Pharmaceuticals USA and Teva Pharmaceutical Industries alleging patent infringement over the emtricitabine component of Truvada and Atripla. ...

Immunomedics says cancer drug met goal in trial 10:25 AM 5/15/2009
Forbes - NY,USA
Immunomedics Inc said its drug candidate epratuzumab succeeded in a clinical trial. Most of the diffuse large B-cell lymphoma patients survived more than a year without further treatment. ...

GlaxoSmithKline to Develop H1N1 Influenza Vaccine 8:00 AM 5/15/2009
SmartMoney
GSK expects to manufacture a candidate A (H1N1) adjuvanted influenza vaccine after virus seed is made available by the WHO. The first doses are expected four to six months later. ...

Pfizer offers free drugs to unemployed, uninsured 11:00 AM 5/14/2009
The Associated Press
Pfizer Inc unveils program where people can keep taking some widely prescribed Pfizer medications for free for up to a year if they've lost their jobs and health insurance. ...

FDA approves UCB drug for rheumatoid arthritis 4:21 PM 5/13/2009
The Associated Press
UCB received US FDA approval for injectable drug Cimzia for patients with moderate to severe rheumatoid arthritis. The injectable was previously approved to treat Crohn's disease. ...

<- Day Earlier | Today's News